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Transforming growth factor-α (TGFα) and fibroblast growth factor-7 (FGF7) exhibit distinct expression patterns in the mammary gland. Both
factors signal through mitogen-activated kinase/extracellular regulated kinase-1,2 (MAPKERK1,2); however, their unique and/or combined
contributions to mammary morphogenesis have not been examined. In ex vivo mammary explants, we show that a sustained activation of
MAPKERK1,2 for 1 h, induced by TGFα, was necessary and sufficient to initiate branching morphogenesis, whereas a transient activation (15 min)
of MAPKERK1,2, induced by FGF7, led to growth without branching. Unlike TGFα, FGF7 promoted sustained proliferation as well as ectopic
localization of, and increase in, keratin-6 expressing cells. The response of the explants to FGF10 was similar to that to FGF7. Simultaneous
stimulation by FGF7 and TGFα indicated that the FGF7-induced MAPKERK1,2 signaling and associated phenotypes were dominant: FGF7 may
prevent branching by suppression of two necessary TGFα-induced morphogenetic effectors, matrix metalloproteinase-3 (MMP-3/stromelysin-1),
and fibronectin. Our findings indicate that expression of morphogenetic effectors, proliferation, and cell-type decisions during mammary organoid
morphogenesis are intimately dependent on the duration of activation of MAPKERK1,2 activation.
© 2007 Published by Elsevier Inc.Keywords: MAPKERK1,2; Kinetics; Mammary; Branching; Morphogenesis; TGFα; FGF7Introduction
Branch formation in the mammary gland results from an
intricate interplay between cell intrinsic and extrinsic factors.
These extracellular factors can be grouped broadly into, but not
limited to, hormones, growth factors, proteases, and the
extracellular matrix (ECM), each of which have been demon-
strated to be required for normal mammary development (Fata
et al., 2004; Hovey et al., 2002; Parmar and Cunha, 2004;
Schedin et al., 2004; Sternlicht, 2006).
Members of the epidermal and fibroblast growth factor
receptor (EGFR, FGFR) families are required for normal
mammary development (Mailleux et al., 2002; Sternlicht,
2006), and a number of growth factors have been shown to⁎ Corresponding authors. 1 Cyclotron Rd, Berkeley, CA 94710MS977R225A,
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doi:10.1016/j.ydbio.2007.03.013have functional roles including EGFR and FGFR ligands
(Luetteke et al., 1999; Mailleux et al., 2002; Sternlicht et al.,
2005). A major unresolved question is how these signals are
temporally integrated to generate the diverse range of
morphogenetic behaviours observed during mammary devel-
opment and differentiation.
The mitogen-activated protein kinase (MAPK) pathway
includes a three kinase cassette of Rous sarcoma associated
factor (Raf), mitogen-activated protein/ERK kinase (MEK), and
extracellular regulated kinase (ERK), producing a sequential
activation pathway responsive to a diverse array of extracellular
stimuli (Roux and Blenis, 2004). A fundamental question of
signal transduction is how the canonical components of the
MAPK pathway, Raf→MEK → ERK, integrate signals from
multiple stimuli into distinct cellular outcomes (Marshall, 1995;
Schlessinger, 2004). For instance, the rat pheochromocytoma
PC12 cell line proliferates in response to EGF but differentiates
in response to nerve growth factor (NGF), although both stimuli
elicit activation of the Raf → MEK → ERK cassette (Qui and
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question have focused on the duration of the signal through
ERK-1 and ERK-2 (MAPKERK1,2) as a key factor determining
the fate of a single cell or groups of cells grown on tissue culture
plastic. Intense MAPKERK1,2 phosphorylation is evident by
whole-mount immunohistochemistry in the course of the
development of certain organs during mouse embryogenesis,
including the branchial arches, limbs, and lung buds (Corson et
al., 2003). Prolonged activation of MAPKERK1,2, in response to
hepatocyte growth factor, is associated with immortalized
kidney cells undergoing tubulogenesis in collagen type-1 gels
(Karihaloo et al., 2004; Maroun et al., 1999). Signalling through
the MAPKERK1,2 pathway is necessary for the development of
branched organs such as the lung (Kling et al., 2002), kidney
(Hida et al., 2002), and salivary gland (Kashimata et al., 2000),
but whether the duration of MAPKERK1,2 phosphorylation is
indeed a developmentally relevant regulator of organogenesis
has not been addressed.
To examine the interplay between growth factor signals,
MAPKERK1,2 activation, and mammary branching morphogen-
esis, we utilized an organotypic 3D mammary primary culture
that models aspects of branching morphogenesis in vivo and is
responsive to growth factors produced in the mammary gland.
In this assay, the mammary epithelium is separated from most of
the stroma but retains epithelial/myoepithelial spatial organiza-
tion, allowing us a framework to evaluate the precise role of
signalling modules in a controlled and reproducible environ-
ment. We show that individually as well as in combination,
TGFα and FGF7 elicit distinct kinetics of MAPKERK1,2
activation that in turn predicts both cellular and morphogenetic
outcomes.
Materials and methods
Isolation of primary mammary organoids
The 4th inguinal mammary glands were removed from 10 to 14 weeks old
virgin Balb/c mice and minced with two parallel razor blades (approved by the
Animal Welfare and Research Committee (AWRC) at Lawrence Berkeley Labs;
animal protocol #0522). At this age the expansion of the ductal tree within the fat
pad is complete and no terminal end buds exist. Minced tissue (4–8 glands) was
gently shaken for 30 min at 37 °C in a 50-ml collagenase/trypsin mixture (0.2%
trypsin, 0.2% collagenase type IV, 5% fetal calf serum, 5 μg/ml Insulin, 50 μg/
ml gentamycin, in 50 ml of DMEM/F12). The collagenase solution was
discarded after centrifugation at 1000 rpm and the pellet was re-suspended in
10 ml DMEM/F12. The suspension was pelleted again at 1000 rpm for 10 min,
re-suspended in 4 ml of DMEM/F12+40 μl of DNase (2 U/μl), and incubated
for 5 min at ambient temperature with occasional shaking. The DNase solution
was removed after centrifugation at 1000 rpm for 10 min. The DNase solution
was discarded and the epithelial pieces were separated from the single cells
through differential centrifugation. The pellet was re-suspended in 10 ml of
DMEM/F12 and pulsed to 1500 rpm. The supernatant was then removed and the
pellet was re-suspended in 10 ml DMEM/F12. Differential centrifugation was
performed at least 4 times. The final pellet was re-suspended in the desired
amount of medium or Matrigel (Growth Factor Reduced Matrigel, BD
Biosciences, San Jose, CA).
Morphogenesis assay
Morphogenesis assays were performed in 96 well culture plates. The culture
had two layers, an underlay of 50 μl of Matrigel (Growth Factor ReducedMatrigel, BD Biosciences) and an overlying layer of organoids suspended in
Matrigel. The underlay was allowed to set for 30 min at 37 °C, and then a 50-μl
suspension of organoids in Matrigel (∼100–200 organoids/100 μl of Matrigel)
was added to the well followed by an incubation of 30 min at 37 °C. All wells
were then treated with 150 μl of basal media (DMEF/F12 with 1% insulin,
transferrin, selenium, and 1% penicillin/streptomycin) for 24 h. After 24 h the
basal media was replenished (untreated samples) or growth factors TGFα (9 nM;
Sigma, Saint Louis, MO), FGF7 (9 nM; Sigma, Saint Louis, MO), or FGF10
(9 nM; Biosource, Camarillo, CA) were added to basal media individually or in
combinations. Every other day all samples were replenished with basal media
alone. To determine the morphogenic response we counted all organoids within
each well (∼100–200 organoids/well) having 3 or more branches and divided
this number by the total number of organoids per well (Simian et al., 2001). For
inhibition of MAPKERK1,2 signaling, PD98059 (Calbiochem, San Diego, CA)
was added to growth factor-supplemented medium at a concentration of 40 μM.
Inhibition of MMP-3 was accomplished with 30 μM of an MMP-3-specific
peptide-based inhibitor containing the sequence Ac-Arg-Cys-Gly-Val-Pro-Asp-
NH2 (Calbiochem). The broad based metalloproteinase inhibitor, GM6001, was
added to media at 40 μM. Inhibition of fibronectin adhesion was accomplished
with blocking antibodies against α5β1-integrin (Chemicon, Temecula, CA) at a
concentration of 2 μg/ml.
RT-PCR
Total RNAwas isolated with QIAGENRNeasyMini Kit (Valencia, CA). For
cDNA synthesis, 20 ng of total cellular RNAwas used to synthesize cDNA using
SuperScript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA).MMP-
3 was amplified with GTTCCTGATGTTGGTGGCTT and AGCCTTGGCT-
GAGTGGTAGA primers. Primers that detect fibronectin were TACCAAGGT-
CAATCCACACCCC and CAGATGGCAAAAGAAAGCAGAGG. As a
control for total RNA, RT-PCR for GAPDH was performed with primers
TGAAGGTCGGTGTGAACGGATTTGGC and CATGTAGGCCATGAG-
GTCCACCAC. The amplified fragments were resolved on 1% agarose gels
and products were detected with a FluorChem 8900 analysis system (Alpha
Innotech, San Leandro, CA). Real-time PCR was performed using LightCycler
System (Roche Diagnostics, Indianapolis, IN) according to the manufacturer's
instructions. Fast Start DNA Master SYBR Green I (Roche Diagnostics,
Indianapolis, IN) was used for PCR reaction. PCR data were analyzed with
LightCycler Software ver.3 (Roche Diagnostics, Indianapolis, IN). Relative
signals between fibronectin or MMP3 and 18s rRNAwere quantified.
Protein isolation
For protein isolation, media were removed from the well, and Matrigel+
organoids were washed once with cold 1× PBS containing NaF (1 mM) and
Na3VO4 (1.25 mM). Matrigel and organoids were then treated with a 3D lysis
solution consisting of 90% NP40 lysis mix (50 mM Tris–HCl, pH 8.0, 5 mM
EDTA, 150 mM NaCl, 0.5% NP40) plus 10% 10× SDS loading buffer (83.3 μl
12 M acetate [70% glacial acetic acid (17.4 M) and 30% water], 3.67 ml water,
1.25 μl 2-mercaptoethanol, 0.01 g bromophenol blue, 5.0 ml glycerol, 1 g SDS).
Samples were pipetted up and down and stored at −20 °C. The 3D lysis solution
was heated to 65 °C just prior to using.
Immuno-detection of MAPKERK1,2 phosphorylation
For immunoblot analysis, protein samples were heated at 65 °C for 5 min
then placed on ice for 3–5 min. Samples were centrifuged at 13000 rpm for
5 min and the soluble portion was resolved on a pre-cast 10% Tris–glycine
polyacrylamide gel (InVitrogen, Carlsbad, CA) using the NOVEX system
(InVitrogen, Carlsbad, CA). Resolved proteins were transferred to Hybond
nitrocellulose (Amersham, Piscataway, NJ) followed by blocking in 1× TBS,
0.1% Tween-20 with 5% w/v non-fat dry milk for 1 h at ambient temperature.
Membranes were incubated overnight at 4 °C in 5%BSA, 1× TBS, 0.1% Tween-
20 containing rabbit anti-human polyclonal antibodies that recognize either
phosphorylated MAPKERK1,2 (Thr202/Tyr204, #9101, Cell Signaling Tech.,
Beverly, MA), phosphorylated MEK1 (Ser 298, #9128, Cell Signaling Tech.,
Beverly, MA), total MAPKERK1,2 (#9102, Cell Signaling Tech., Beverly, MA),
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determination of total MAPK was performed on separate membranes using
identical samples. Primary antibodies were detected with the Pierce SuperSignal
detection kit (Rockford, IL) and signal was captured with the FluorChem 8900
analysis system (Alpha Innotech, San Leandro, CA).
Immunocytochemical detection of Ki67, keratins, and receptors
For detection of Ki67, keratin-8 (K8), keratin-14 (K14), and keratin-6 (K6),
a mixture of 18% sucrose in PBS (15 min at ambient temperature) followed by
30% sucrose (15 min at ambient temperature) was applied to organoids in
Matrigel to maintain organoid structure. After sucrose treatment, organoids in
Matrigel were gently pipetted up and down and then smeared onto a glass slide.
Smeared organoids were allowed to dry at ambient temperature for 2 h and then
fixed in methanol: acetone (1:1 v/v) at −20 °C for 10 min. After fixation, slides
were air-dried at ambient temperature for 2 h followed by blocking in 10% sheep
serum in PBS for 1 h at ambient temperature. The primary antibodies, rabbit
polyclonal anti-human Ki67 (Ki67p, Novocastra, UK), rat monoclonal anti-
mouse K8 (Troma-1, Iowa DSHB, Iowa City), mouse monoclonal anti-human
K14 (clone #LL002, Novocastra, UK), rabbit polyclonal anti-mouse-K6 (PRB-
169P, Covance Research Products, Berkeley), goat polyclonal anti-human
FGFR2 (Bek N-20, Santa Cruz Biotechnology, Santa Cruz, CA), and rabbit
polyclonal anti-human EGFR (#2232, Cell Signaling Tech., Beverly, MA) were
incubated in blocking buffer overnight at 4 °C, followed by 3×15 min washes in
0.5% Triton-X in PBS. For detection of primary antibodies, appropriate
fluorophore-labeled secondary antibodies were used and images were captured
using confocal microscopy. The generation of confocal stack montages and
generation of threshold images for calculating double positive keratin cells were
accomplished with ImageJ (NIH).
Live–dead cell detection
To determine the ratio of live to dead cells, we used Molecular Probes
(Carlsbad, CA) LIVE/DEAD Viability/Cytotoxicity Kit, which provides a two-
color discrimination of live and dead cell populations. For live cells a membrane
permeant calcein AM, which is cleaved by intracellular esterases in live cells to
yield cytoplasmic green fluorescence, was added to the assay. Dead cells, which
have a compromised plasma membrane, were stained with the membrane
impermeant nucleic acid dye, ethidium homodimer-1 yielding a red fluores-
cence. Both labels were incubated for 30 min at 37 °C and then visualized by
fluorescent microscopy after excitation.
Real-time microscopy
Time-lapsemovieswere collected on a ZeissAxiovert S-100microscope using
a 10× A-Plan objective lens and a Cohu high performance CCD camera. The light
exposure was regulated by a Ludl shutter and controller, which also controlled the
Ludl x–y–zmotorized stage. Temperature was held at 37 °C and carbon dioxide
at 5% using a CTI Controller 3700 and Temperature Control 37.2 combination.
Images were acquired at each of 48 positions every 15 min using a custom
macro implemented in OpenLab 4.0.2. (Improvision Inc., Lexington, Mass).Results
TGFα induces branching morphogenesis in primary mammary
organoids cultured within a 3D ECM gel
To examine mammary morphogenesis, we developed an
organotypic 3D culture system consisting of primary mammary
organoids (which contain both the epithelium and the
myoepithelium, but not the adipogenic stroma) within a 3D
laminin-rich extracellular matrix (3D lrECM; Matrigel). The
basal medium is chemically defined (see Materials and
methods) and was designed to support cell survival, but notinduce branching morphogenesis (Fig. 1A). TGFα in concen-
trations between 1 nM and 100 nMwere added to the organoids,
and all doses were sufficient to induce branching. We chose a
dose of 9 nM for TGFα for all experiments described because it
was shown previously by us that 9 nM of EGF induces
branching morphogenesis of mammary organoids in collagen
type I gels (Simian et al., 2001). Branching occurred with
similar frequency and pattern whether we added TGFα to the
medium only once in the beginning of the assay or every other
day (data not shown). Time-lapse microscopy showed that
branch formation in TGFα-treated organoids was evident
within the first 48 h, with the majority of bud initiation and
extension observed between 48 and 72 h (Fig. 1A and
Supplemental Movie 1). Branch extension, however, was
limited, often resulting in a short stalk. Untreated organoids
did not initiate new branches but reorganized to form acinar-like
structures (Fig. 1A and Supplemental Movie 2).
FGF7 suppresses TGFα-induced morphogenesis
The mammary gland undergoes a diverse range of
morphogenetic transformations during puberty, pregnancy,
lactation, and involution. Which growth factors act in what
combination to bring about this diversity is still poorly
understood. We chose to examine the known mammary
mitogens, TGFα and FGF7, since the two factors exhibit both
distinct and overlapping temporal and spatial regulation. TGFα
is expressed primarily in mammary epithelial cells and is
elevated during branching morphogenesis and pregnancy-
induced alveologenesis (Liscia et al., 1990). FGF7 is expressed
primarily in the stroma, is high prior to the onset of extensive
branching and declines thereafter, becoming minimal during
alveologenesis (Mailleux et al., 2002; Pedchenko and Imagawa,
2000). We asked whether the actions of these two factors
through MAPKERK1,2 were in fact redundant for morphogenesis
or whether the response of organoids to FGF7 was distinct from
that of TGFα. Whereas TGFα induced branching, FGF7
induced growth (Fig. 1B and Supplemental Movie 3).
Morphometric analysis showed that approximately 80% of
organoids produced branches within 5 days in response to
TGFα; the rest resembled the untreated controls (Fig. 1C).
Surprisingly, when FGF7 was added together with TGFα, it
suppressed TGFα-induced branching in a dose-dependent
fashion (Figs. 1B and C). A ratio of 4:1 (FGF7:TGFα) led to
an approximately 80% inhibition of morphogenesis in compar-
ison to TGFα alone (Fig. 1C). Time-lapse video microscopy
indicated that unlike TGFα alone, FGF7+TGFα induced
extensive lumen expansion, and those organoids that did branch
were aberrant with morphologies similar to FGF7 alone (Figs.
1B and C and Supplemental Movie 4), indicating that the FGF7
phenotype was dominant over TGFα-induced branching.
TGFα and FGF7 induce distinct MAPKERK1,2 phosphorylation
kinetics
TGFα and FGF7 signal through different receptors, yet
each ligand is a potent activator of MAPKERK1,2. To
Fig. 1. Organoid response to TGFα and FGF7. (A) Untreated organoids fail to undergo major morphological changes, except a slight lumen expansion followed by
compression from 48 to 60 h. In contrast, TGFα stimulation initiates bud formation (arrows) within 48 h, with the majority of morphogenesis occurring within the
48- to 72-h window. Images represent frames taken from movies (Supplemental Movies 1 and 2). (B, C) FGF7 fails to induce branching morphogenesis and
suppresses TGFα-induced morphogenesis in a dose-dependent manner. Please see Supplemental Movies 3 and 4. (C) Morphometric analysis of branching
morphogenesis. Scale bars represent 100 μm. Data are represented as mean morphogenetic response±standard deviation (SD) and involve counting at least 100
organoids per condition per experiment.
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different morphogenetic outcomes despite using the same
signalling pathway, we assayed the phosphorylation kinetics of
MEK1 and MAPKERK1,2 by immunoblotting protein lysates
that were isolated at discrete time points after growth factor
stimulation using anti-phospho-MEK/MAPKERK1,2 antibodies.
TGFα stimulation induced rapid phosphorylation of both
MEK1 (Fig. 2A) and MAPKERK1,2 (Fig. 2B), which peaked as
early as 15 min and was sustained for up to 1 h. Between 1
and 2 h after TGFα stimulation, phospho-MEK1 and phospho-MAPKERK1,2 levels decreased but remained well above the
basal levels for at least 24 h (Figs. 2A, B and data not shown).
FGF7 stimulation of organoids also led to induction of both
MEK1 and MAPKERK1,2 phosphorylation, but in contrast to
TGFα, high levels of these kinases were evident for only
15 min (Figs. 2A, B).
Since we already knew that simultaneous addition of FGF7
and TGFα leads to a morphogenetic outcome similar to that of
FGF7 alone, it was not surprising that the phospho-MAPKERK1,2
duration also resembled the FGF7-like pattern (Fig. 2B).
Fig. 2. FGF7 attenuates TGFα-induced MAPKERK1,2 activation. (A, B) Activation of high MEK1 (P-MEK1) and MAPKERK1,2 (P-p44, P-p42) levels are sustained for
1 h in organoids stimulated with TGFα compared to only 15 min in organoids stimulated with FGF7. Actin and total MAPKERK1,2 (p44, p42) are provided as loading
controls. (B) FGF7 attenuates TGFα activation of MAPKERK1,2 when the growth factors are added simultaneously to the organoids. (C) Quantitative analysis of
MAPKERK1,2 activation: MAPKERK1,2 activation in organoids treated with TGFα is significantly different than those treated with FGF7 *[ p<0.05], or those treated
with FGF7 plus TGFα at 30, 60, and 180 min. Data are represented as the mean of phospho-MAPKERK1,2 levels/total MAPKERK1,2±standard deviation (SD).
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revealed a significant difference in the first 3 h between
organoids stimulated with TGFα compared to organoids
stimulated with FGF7 alone or with both FGF7 and TGFα
(Fig. 2C; *p<0.05).A brief window of TGFα-induced MAPKERK1,2 activation
sustains a prolonged morphogenetic program
Given the results obtained above, we asked (a) whether the
MAPK pathway was responsible for the morphogenetic
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could be sufficient to elicit the entire 5-day morphogenetic
program. Pre-treatment of organoids with PD98059 (20 μM),
an inhibitor of MAPKERK1,2 phosphorylation for 1 h prior to
TGFα stimulation inhibited MAPKERK1,2 activation (Fig. 3A),
and abolished branching morphogenesis (Fig. 3Bb and
Supplemental Movie 5; compare to TGFα treatment alone
(Fig. 3Ba) and Supplemental Movie 1). Similar results were
seen when PD98059 (40 μM) was added simultaneously with
TGFα (Fig. 3Bc). However, addition of PD98059 at 1, 4, 24,
48, or 72 h, post-TGFα stimulation, yielded a partial decrease
in branching morphogenesis (Fig. 3Bb; and data not shown),
indicating that the initial 1 h phosphorylation of MAPKERK1,2
was necessary and sufficient for transducing the MAPKERK1,2-
dependent component of the TGFα signal for branching.
PD98059 added 1 h after TGFα stimulation was effective in
inhibiting branches in 50% of organoids vs. 10% when it was
added 4 h after TGFα stimulation (Fig. 3Be; compare to
TGFα stimulation alone). The incomplete response to 1 h of
TGFα activation suggests that additional and as yet undeter-
mined factors may be necessary to allow the organoids to fully
respond to TGFα. However, the inability of PD98059 toFig. 3. One hour of MAPKERK1,2 activation is necessary and sufficient for TGFα-ind
activation. PD98059, the MEK inhibitor, suppresses TGFα-induced MAPKERK1,2 ac
P-p42) and total MAPKERK1,2 (p44/p42) were visualized on the same membrane in
(a) TGFα alone. Pre-treatment with PD98059 for 1 h (b), or simultaneous addit
Supplemental Movie 5). Addition of PD98059 at 1 h (d) or 4 h (not shown) after TGF
percentage of organoids undergoing a morphogenetic response similar to TGFα-t
c=TGFα+PD98059 added simultaneously, d=PD98059 added after 1 h of TGFα s
50 μm. Data are represented as mean morphogenetic response±SD and involve cosignificantly inhibit branching after 4 h indicate that the
majority of molecules necessary for branching are induced
before the 4-h period. It should also be noted that it is not
possible to tightly control ERK activation kinetics with
PD98059 since the inhibitor functions by inactivating MEK
that is not activated and does not affect activated MEK (Ballif
and Blenis, 2001).
MMP-3 and fibronectin mediate TGFα-induced mammary
morphogenesis
To investigate MAPKERK1,2-dependent downstream effec-
tors of TGFα-induced morphogenesis, we screened candidate
genes suspected of being involved in branching using
quantitative RT-PCR on samples isolated after TGFα stimula-
tion with or without PD98059. In a screen of a panel of a
number of factors reported to be necessary for branching which
included matrix metalloproteinase-3 (MMP-3), MMP-9, MMP-
14, tissue inhibitor of metalloproteinase-1 (Timp-1), urokinase
plasminogen activator (uPA), epimorphin (EPM), and Twist,
only MMP-3 and fibronectin registered positive as being both
induced by TGFα and dependent on MAPKERK1,2 activationuced morphogenesis. (A) TGFα induces a rapid increase in active MAPKERK1,2
tivation when added 1 h before TGFα stimulation. Active MAPKERK1,2 (P-p44/
each condition. Membranes were transferred and developed simultaneously. (B)
ion with TGFα at time 0 h (c), completely inhibits morphogenesis (see the
α treatment fails to inhibit morphogenesis completely. (C) Quantification of the
reated samples (a=untreated, b=PD98059 pre-treatment followed by TGFα,
timulation, e=PD98059 added after 4 h of TGFα stimulation). Scale bar equals
unting at least 100 organoids per condition per experiment.
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and fibronectin mRNA expression was relatively low (Fig. 4A;
the level of MMP-3/18s was 0.23±0.2 and that of fibronectin/
18s was 0.25±0.4—data are presented as mean ratio of each
mRNA/18s rRNA±standard deviation as determined by
quantitative real-time PCR). After TGFα stimulation, MMP3
and fibronectin mRNA displayed a 9-fold induction (Fig. 4A;
MMP-3/18s, 2.18±0.2; fibonectin/18s, 3.37±0.9). Up-regula-
tion of both MMP-3 and fibronectin by TGFα was suppressedFig. 4. Inhibition of MMP-3 activity and fibronectin adhesion alters TGFα-induced m
MMP-3 and fibronectin. (B) FGF7 inhibits TGFα-induced expression of fibronecti
fibronectin mRNA/18s±SD. (C) A peptide-based inhibitor specific to MMP-3 (20
morphogenesis and often leads to formation of cyst-like structures. (D) Addition of a b
morphogenesis, while a non-specific isotype IgG antibody (2 μg/ml) has no effect. Q
under different conditions. Data are represented as mean morphogenetic response±SD
bars in panels C and D equal 200 μm.significantly when PD98059 was added to the cultures (Fig. 4A;
0.70±0.30 MMP-3/18s and 0.86±0.3 fibronectin/18s). Impor-
tantly, FGF7 added alone failed to induce MMP-3 and
fibronectin (data not shown), and when added with TGFα, it
significantly suppressed the TGFα-induced up-regulation of
fibronectin (0.56±0.03 vs. 2.18±0.2 fibronectin/18s; Fig. 4B).
Interestingly, TGFα-induced MMP-3 up-regulation was inhib-
ited by only 50% (1.48±0.89 vs. 3.37±0.9 MMP-3/18s;
p=0.08) in the presence of FGF7.orphogenesis. (A) TGFα induces MAPKERK1,2-dependent mRNA expression of
n mRNA levels (quantitative PCR). Data are represented as the mean ratio of
μM) or the general metalloproteinase inhibitor, GM6001 (40 μM) suppresses
locking antibody (2 μg/ml) against the fibronectin receptor, α5β1 integrin alters
uantification represents the percentage of structures undergoing morphogenesis
and involve counting at least 100 organoids per condition per experiment. Scale
Fig. 5. MAPKERK1,2 regulates organoid proliferation and apoptosis. (A) TGFα-induced proliferation (determined by Ki67 immunocytochemistry with DAPI counter
stain for nuclei) is inhibited by PD98059 but augmented by FGF7. (B) Live cells are labeled with the vital dye Calcein AM (green) and dead cells are labeled with
ethidium homodimer-1 (orange). Dead cells are prevalent in untreated and PD98059-treated organoids. (C) Organoids treated with FGF7 show continued
proliferation on day 4. (C) TGFα plus PD98059-treated and control organoids analyzed at day 2 or day 4 have significantly higher apoptosis than those treated with
TGFα or FGF7. *Significantly different than all other conditions. Scale bars equal 50 μm. Data are represented as mean percent Ki67±SD and mean percent
apoptosis±SD and involve counting at least 10 randomly selected organoids per condition per experiment.
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TGFα-induced morphogenesis, we inhibited MMP-3 by a
relatively selective peptide-based inhibitor (MMP-3 Inhibitor
I). Morphogenesis was suppressed by about ∼50%, often re-
sulting in cyst-like structures containing a few stunted branches
(Fig. 4C). However, a broad-spectrum inhibitor against all
MMPs (GM6001) completely abolished branching and led to
either small, underdeveloped acini (similar to Fig. 3Bb) or
large, cyst-like structures as seen also with MMP-3 Inhibitor 1
(Fig. 4C).
Fibronectin inhibition was achieved by preventing its
binding to its major receptor, α5β1 integrin, using inhibitory
antibodies. Morphogenesis was completely suppressed in
approximately 40% of the organoids compared to the control
antibodies which did not suppress (Fig. 4D). Those structures
that did form in the presence of the inhibitory antibody had
abnormal and often thick, underdeveloped branches (Fig. 4D).
Thus, while other factors may be required, it is clear that bothFig. 6. Orientation of myoepithelial and epithelial cells is maintained in organo
myoepithelium) and K8 (green; epithelium) in cultured organoids was captured by co
cells. Myoepithelial cells are the larger cells displaying membrane extensions; the
organoids, day 4. (B) TGFα-treated organoids, day 4. (C) FGF7-treated organoids, da
C and indicate that cells at the distal ends of branches in panel B are K8/K14 double po
or FGF7. Scale bars in panel A equal 5 μm (left panel) and 50 μm (right panels). Sthese candidate genes are necessary for TGFα induction of
branching.
MAPKERK1,2 regulates organoid proliferation and apoptosis
It has been argued that differentiation and growth are often
incompatible in morphogenesis. To additionally explore the
underlying reasons for the differences in response, we
explored whether TGFα and FGF7 elicited different growth
responses from the organoids. At day 2, organoids treated with
TGFα, FGF7, or a combination of the two, had significantly
higher Ki67-positive cells than untreated organoids (Figs. 5A,
C). The TGFα-induced proliferation was dependent on
MAPKERK1,2 activation since it was completely suppressed
in organoids pre-treated with PD98059 (Figs. 5A, C). By day
4, TGFα-treated organoids stopped growing as shown by the
absence of Ki67-positive cells (Fig. 5A) whereas organoids
treated with FGF7 or FGF7 plus TGFα continued toids undergoing morphogenesis. Indirect immunofluorescence for K14 (red;
nfocal microscopy. (A–C) Epithelial cells are the small tightly packed cuboidal
y retain their basal orientation with respect to epithelial cells. (A) Untreated
y 4. A montage of merged K8/K14 confocal stacks is represented in panels B and
sitive (yellow signal). Lumena (*) are evident in all structures treated with TGFα
cale bars in panels B and C equal 50 μm.
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5A, C). Thus, the difference in mode of action of the two
growth factors is not due to differences in the initial growth
phase but may result partially from continued proliferation in
the presence of FGF7.
To complete the analysis, we measured cell death under
these different conditions. A significant number of dead cells
were evident at both day 2 and day 4 in untreated organoids or
in TGFα-stimulated organoids when pre-treated with PD98059
(Figs. 5B, C). In contrast, none of the growth factor-treated
organoids had appreciable dead cells either at days 2 or 4, and
there were no significant differences between TGFα- and
FGF7-treated organoids (Figs. 5B, C). Thus, the kinetics of
proliferation, and not apoptosis, is an additional defining
feature associated with the different morphogenetic response
of the two growth factors.
TGFα and FGF7 retain myoepithelial–epithelial polarity
We have shown that acinar polarity is crucial in determining
the rate of apoptosis in response to a number of chemother-
apeutic agents and also a significant feature distinguishing
normal and malignant epithelial cells (Weaver et al., 2002). The
absence of a difference in apoptosis raised the possibility that
the juxtaposition of the myoepithelial/epithelial cells, which
determines basal tissue polarity (Gudjonsson et al., 2002), may
be different under the two conditions. We performed immuno-
cytochemistry using antibodies against K14 and K8, which
detect myoepithelial and luminal epithelial cells, respectively.
Confocal microscopic analysis of K14 immunostaining after
1 day of culture revealed that untreated organoids maintained a
basal layer of K14-positive myoepithelial cells possessing long
cellular processes and an inner layer of K8-positive luminal
epithelial cells (Fig. 6A). Myoepithelial cells were numerous
and they did not completely encapsulate the organoids but
instead appeared to be woven around the luminal epithelial cells
(Fig. 6A). Thus, the luminal epithelium is likely to have
extensive direct contact with the BM, an arrangement that is
observed also in vivo (Emerman and Vogl, 1986).
Organoids that had undergone branching morphogenesis
after TGFα treatment had a similar spatial arrangement; with
K14 myoepithelial cells surrounding K8 epithelial cells (Fig
6B). Intriguingly, a large subset (17.5±3%) of the cells co-
expressed both K14 and K8 (yellow in merged images Fig. 6B;
Supplemental Fig. 1) after TGFα treatment. These cells were
invariably located at the distal ends of branches and may
represent a subset of progenitor luminal cells (Pechoux et al.,
1999; Shackleton et al., 2006). In untreated organoids, very few
cells co-expressed K8 and K14 (1.4±0.2%; Supplemental Fig.
1). An examination of FGF7-treated or FGF7-TGFα dual-
treated organoids revealed a similar orientation of myoepithe-
lium to epithelium as that seen in TGFα-treated organoids (Fig.
6C, and data not shown), but fewer K8/K14 double positive
cells were evident in the FGF7-treated compared to TGFα-
treated organoids (Supplemental Fig. 1). Under all conditions,
all organoids examined retained their central lumena. The
developing branches also all contained lumena (Fig. 6).FGF7 induces MAPKERK1,2-dependent increase in K6-positive
cells
K6-positive cells were previously shown to be localized to
hyperproliferative areas in the mouse mammary gland and skin;
this keratin has been considered a putative marker of stem/
progenitor mouse mammary cells in some studies (Li et al.,
2003; Welm et al., 2005). Since FGF7 induced sustained
proliferation in the organoids, we asked whether it also induced
higher numbers of K6-positive cells. Only a few K6-positive
cells were evident in untreated and TGFα-treated organoids
(Fig. 7A). When found, the K6-positive cells were rarely
evident in the distal ends of branches and were found only at
the base of branches (Figs. 7A, B). FGF7, alone or in
combination with TGFα, induced a significant increase in the
number of K6-positive cells compared to TGFα-treated
organoids (Figs. 7A, B). Up-regulation of K6 expression
occurred as early as 48 h after FGF7 stimulation (data not
shown). The large numbers of K6-cells encapsulating the
organoids were often found within the outer distal cell layers
(Figs. 7A, B). We also noted that there were at least two
populations of K6-positive cells in FGF7- or FGF7+TGFα-
treated organoids: those that were K6+/K8+ and those that were
basal K6+/K14+ (Fig. 7B; Supplemental Figs. 2 and 3).
The FGF7-dependent effects also were MAPKERK1,2-
dependent. Treatment with PD98059 prior to FGF7 or
FGF7+TGFα stimulation inhibited both the increase in
proliferation and the increase in the number of K6-positive
cells in organoids stimulated with FGF7 (Fig. 7C; compare
proliferation with 5C). As seen with TGFα-cultures, suppres-
sion of MAPKERK1,2 in FGF7-treated organoids also increased
the number of dead cells close to the level of untreated controls
(compare Fig. 7C with Fig. 5C).
Since FGF10 and FGF7 signal through a common isoform of
FGFR2 referred to as FGFR2-iiib, we reasoned that many of the
FGF7-associated phenotypes would be elicited also by FGF10.
As expected, FGF10 failed to induce branching morphogenesis,
inhibited TGFα-induced branching morphogenesis in a dose-
dependent fashion, and up-regulated keratin-6 expression
(Supplemental Fig. 4).
Discussion
Mammary branching morphogenesis requires exquisite time-
dependent coordination of signaling between the ECM,
hormones, and growth factors. It is not yet possible to do
rapid time course and multifactorial analysis in vivo. Thus,
despite intense study of the individual components, we know
little about the precise signaling pathways, and the kinetics and
mode of interactions among the different morphogenetic
effectors. We developed a physiologically relevant, laminin-
rich 3D assay where organoids from a few mice provide ample
replicates and time points for such analysis.
We show that two growth factors produced by the mammary
gland, TGFα and FGF7, induce very different outcomes in
mammary organoids. A 1-h treatment with TGFα, followed by
inhibition of MAPKERK1,2, was sufficient to induce a program
Fig. 7. FGF7 induces MAPKERK1,2-dependent increase in K6-positive cells as well as organoid proliferation. (A) FGF7-induced K6-positive cells are evident on the
outside of the organoid (day 4). (B) K6-positive cells in TGFα-treated organoids remain at the base of the branch, while K6-positive cells in FGF7-treated organoids are
found both encapsulating and within the organoid. Some of these K6-positive cells are K8/K6 double positive (yellow). (C) FGF7-induced proliferation and increase in
K6-positive cells is dependent on MAPKERK1,2 activation. Scale bar in panel A equals 25 μm, in panel B equals 100 μm, and in panel C equals 25 μm.
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treatment led to sustained growth and to formation of
continuously growing cysts. We showed that whereas both
factors signal through the MAPKERK1,2 pathway, TGFα
stimulation leads to high levels of MEK1, MAPKERK1,2
phosphorylation for at least 1 h, while FGF7 induces a shorter
duration (15 min) of phosphorylation. When the two factors are
added together, the FGF7 MAPKERK1,2-dependent phenotype
dominates and suppresses TGFα-induced branching (see
Supplemental Movies 1–5).
Our data build upon the seminal work that found
MAPKERK1,2 kinetics could determine the fate of PC12 cells
cultured on conventional 2D plastic (Qui and Green, 1992;
Traverse et al., 1992). These investigators found that EGF
induced a rapid and transient induction of MAPKERK1,2
leading to cellular proliferation, while NGF induced a rapidbut more prolonged phosphorylation, which in turn led to
cellular differentiation. Therefore, a transient induction of
MAPKERK1,2, in the one case with EGF added to PC12 cells
and here with FGF7 added to mammary organoids,
promotes proliferation. In contrast, a sustained activation of
MAPKERK1,2 in PC12 with NGF promotes neuronal extension
and in mammary organoids with TGFα leads to branching
morphogenesis. The dominance of the FGF7-induced mor-
phogenetic outcome in the mammary gland mediated through
a transient activation of MAPKERK1,2 may be achieved
through sustained activation of growth pathways.
We have published previously that amphiregulin is an
important ligand for branching development of embryonic
mammary tissue and that it signals through the stroma
(Sternlicht et al., 2005). This ligand was also shown to be
important for the branching morphogenesis that initiates at the
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expressed in adult mammary gland tissue (Luetteke et al., 1999,
and our unpublished data), the very tissue we are using in our
study. There is strong evidence that in adult mice, branching
occurs both during the estrous cycle and during gestation and
primarily involves secondary or tertiary branching (Fata et al.,
2001; Robinson et al., 2000; Atwood et al., 2000). Therefore,
growth factors other than amphiregulin must regulate this
morphogenetic process. We suggest that TGFα, which is
expressed in adult mammary gland (Liscia et al., 1990), is a
good candidate factor inducing morphogenesis during this time.
Transgenic overexpression of TGFα in epithelial cells of
the mouse mammary gland induces extensive hyperplasia and
occasional carcinoma (Matsui et al., 1990), and endogenously
produced or exogenously added TGFα inhibits expression of
whey acidic protein (WAP) in primary mammary epithelial
cells (Lin et al., 1995). Others have shown that expression of a
dominant-negative EGFR in mammary epithelium inhibits
ductal morphogenesis (Xie et al., 1997). These three studies
indicate that TGFα is capable of acting directly on epithelial
EGFR. However, transplantation studies and EGFR-null
mammary tissue showed that signaling through stromal
EGFR is required for extensive ductal outgrowth (Wiesen et
al., 1999). Our current data suggest that exogenously added
TGFα in this model system can induce signaling to epithelial
EGFR and may mimic the stromal signaling required in vivo.
It should be noted, however, that the branching seen in our
organoids is more robust and exuberant than the spatially
restricted branching seen in vivo in the mammary gland of
virgin animals. We believe this is because in the 3D assay, the
exogenous TGFα ligand is available to all the epithelial cells
and leads to a global stimulation of the MAPKERK1,2 signal
whereas in vivo there are likely discrete gradients of initiating
or inhibitory signals, such as stromal TGFβ (Daniel et al.,
1996; Nelson et al., 2006).
A possible explanation for the ability of TGFα to induce
branching is that this growth factor induces two known
morphogens, MMP-3 (Simian et al., 2001) and fibronectin
(Sakai et al., 2003), and that these two factors are expressed in
response to a prolonged activation of MAPKERK1,2. In other cell
types in culture, mRNA expression of MMP-3 and fibronectin
also was shown to be dependent on MAPKERK1,2 activation
(Gaggioli et al., 2005; Park et al., 2004). Our previous and
current data provide evidence that MMP-3 controls lateral
branching in vivo (Wiseman et al., 2003) and is required for
growth factor-induced mammary branching in type I collagen
gels (Simian et al., 2001). Other MMPs may also be involved
since complete inhibition of MMP activity with the broad based
MMP inhibitor, GM6001, leads to a more drastic suppression of
morphogenesis than inhibition of MMP-3 alone. Intriguingly,
we found that inhibition of MMPs promotes continued lumen
expansion. We had hypothesized that both down-regulation of
MMP activity and apolar expression of the mammary morpho-
gen, epimorphin, may play a role in formation of acinar lumen
during late pregnancy and lactation (Hirai et al., 1998; Hirai et
al., 2001). The data presented here indicate that FGF7 inhibits
induction of MMP3. Thus, it would be interesting to investigatewhether fibronectin is inhibited when epimorphin leads to
lumen formation.
Fibronectin is a key factor regulating branching in a number
of organs including the salivary gland (Larsen et al., 2006; Sakai
et al., 2003). Here we show that this ECM molecule also
participates in branching in the mammary gland. Inhibition of
the fibronectin receptor (α5β1) using blocking antibodies leads
to altered morphogenesis where branch extensions are reduced
and development verges on abnormal growth. The ability of
FGF7 to suppress fibronectin expression may thus be an
important reason for its ability to be dominant over TGFα‘s
ability to induce branching.
It is intriguing that both TGFα and FGF7 changed the
profile of the keratin-expressing cells and stimulated two
different progenitor cell populations. Whereas TGFα induced
an increase in K8+/K14+ cells, FGF7 increased the number of
K8+/K6+ and K14+/K6+-positive cells. The K8+/K14+ (similar
to K19+/K14+) cell-type has been suggested to represent
luminal progenitor cells (Gudjonsson et al., 2002; Shackleton
et al., 2006). Interestingly, cells double positive for K8+/K14+
are the majority cell type in embryonic urogenital sinus
epithelium and the developing prostatic epithelium and are
considered progenitor/stem cells within these tissues (Wang et
al., 2001). In mammary epithelium, K8−/K14+ cells, which
represent the myoepithelial population, can be derived from
the K8+/K14− luminal epithelium (Pechoux et al., 1999). The
importance of myoepithelial cells in mammary gland biology
and breast cancer has received recent attention (Adriance et al.,
2005; Faraldo et al., 2005). Aside from myoepithelial cells
being important for milk ejection, they have been shown to act
also as natural tumor suppressors which can establish or
maintain acini polarity (Gudjonsson et al., 2002). It may be
reasonable to hypothesize that in the absence of functional
myoepithelial cells, branching morphogenesis would likely not
occur properly. Specific ablation of either myoepithelial
function or myoepithelial cells as a whole could address this
hypothesis and conditional gene targeting could be used, as it
has previously, as an in vivo approach to better understand the
many functions these cells appear to execute (Faraldo et al.,
2005).
A previous study using our assay and organoids from
embryonic (e18.5) mammary glands showed that FGF7 did in
fact induce branching morphogenesis (Sternlicht et al., 2005).
The explanation lies in the fact that at different stages of
mammary gland development, the composition of the ligands
and the receptors change, i.e. this is an age-dependent pheno-
menon. A comparison of organoids from these two different age
groups (embryonic vs. 10–14 weeks old) in the same mouse
background in the same experiment confirmed that the response
of mammary epithelium to FGF7 in 3D cultures is dependent on
the age of the donor mouse (unpublished results). In this report,
we used organoids from adult (10–14 weeks old) mammary
glands, and under these conditions, FGF7 not only fails to
induce branching but also inhibits TGFα-induced morphogen-
esis pointing to the exquisite, stage- and time-dependent
changes that occur in the mammary gland as it develops after
birth. Indeed, expression of both mammary epithelial FGF7
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tally regulated (Coleman-Krnacik and Rosen, 1994; Mailleux et
al., 2002; Pedchenko and Imagawa, 2000), suggesting that the
ratio of ligand to receptor may be one important reason for the
altered morphogenetic outcome.
FGF7-dependent phenotypes were dependent on a transient
induction of MAPKERK1,2 since both proliferation and expan-
sion of K6-positve cells by FGF7 were inhibited completely by
PD98059. K6+ cells were shown to localize to hyperprolifera-
tive areas in Wnt-1 tumors and terminal end buds within the
mouse mammary gland and were proposed also to represent a
marker for stem/progenitor mouse mammary cells (Li et al.,
2003; Welm et al., 2005). Recently, a sub-population of
mammary epithelial cells having high levels of the stem cell
marker Sca-1, and displaying properties of mammary stem/
progenitor cells, were found to be primarily K6 positive
(Deugnier et al., 2006). However, mammary glands examined
from K6-embryonic knockout mice revealed that this keratin
may not be necessary for ductal development, possibly arguing
against K6 as a functional molecule for maintenance of the
stem/progenitor cell population in the mammary gland (Grimm
et al., 2006). The exact mechanism by which FGF7 induces K6
expression while TGFα does not remains to be elucidated. The
difference between these two growth factors may lie in their
ability to induce distinct transcription factors. For instance, in
the development of the Drosophila air sac, which requires both
FGF and EGF signaling, the ets domain transcription factor,
Pointed (downstream of MAPKERK1,2 activation) is needed for
branchless/FGF-induced cell migration but dispensable for
EGF-induced cell proliferation/survival (Cabernard and Affol-
ter, 2005). Although the development of the Drosophila trachea
is quite different from branching morphogenesis in the mouse
mammary gland, the conserved signalling cascades have given
insights into the mechanisms of how different growth factors
elicit different morphogenetic responses within the same tissue.
FGF10 mimicked several of the phenotypes induced by
FGF7, which is consistent with the report that these two growth
factors signal through the common receptor FGFR2-iiib. Both
FGF10 and FGFR2-iiib have been shown to be necessary for
mammary placode/ductal development during embryogenesis
(Mailleux et al., 2002). FGF7-null mice are at least capable of
lactation (Guo et al., 1996), indicating that FGF7 may not be
necessary for functional lobulo-alveolar morphogenesis. How-
ever, to our knowledge there has not been a complete analysis of
the female mammary gland isolated from FGF7-null female
mice—leaving it an open question as to whether this growth
factor is or is not important for mammary branching
morphogenesis in vivo.
We are currently investigating how FGF7 may antagonize
TGFα-induced signalling and morphogenesis. This antagon-
ism would prove difficult to study in the complex in vivo
environment, which could possibly explain the absence of
previous reports on this interesting finding. Our initial efforts
have focussed on determining the localization of the receptors
for TGFα and FGF7 (EGFR and FGFR2 respectively) in
organoids. These efforts have identified an apparent spatial
difference found within the myoepithelial compartment. Spe-cifically, FGFR2 is abundant within myoepithelial cells while
EGFR is restricted to a few myoepithelial cells/organoid
(Supplemental Fig. 5). Within the luminal epithelial compart-
ment, both EGFR and FGFR2 appear to be distributed
homogeneously in all cells. Therefore, FGF7 may antagonize
TGFα-induced signalling and morphogenesis directly in
luminal cells (and the few myoepithelial cells that contain
both EGFR and FGFR2) as well as indirectly by modulating
those myoepithelial cells that lack EGFR. The latter process
would involve a mechanism independent of regulating
MAPKERK1,2 activation. Alterations in these two compart-
ments would affect morphogen expression and cell–cell
communication that together may override TGFα-induced
morphogenesis. How FGF7 antagonizes TGFα activation of
MAPKERK1,2 could involve mechanisms that include aug-
menting EGFR receptor turnover through FGF7-activation of
the ubiquitin ligase Cbl (Schlessinger, 2004), increasing
MAPK phosphatase activity, and/or inhibiting induction of
RAP1 which has been shown to sustain MAPKERK1,2
activation (York et al., 1998). Whereas we cannot be certain
that the TGFα- and FGF7-associated phenotypes are solely
dependent on MAPKERK1,2 activation, our data clearly
indicate that distinct activation kinetics are associated with
distinct phenotypes.
In summary, we find that phosphorylation of MAPKERK1,2
and duration of its activation are directly related to outcome in
the organotypic 3D primary culture system we have developed
to study mammary gland branching morphogenesis. We find
that the interplay between the different growth factors, their
spatial localization, and the duration of their activation as well
as downstream effectors such as MMP-3 and fibronectin
cooperate and choreograph whether mammary branches
initiate and elongate. Finally, the interplay between TGFα
and FGF7 suggests that the mammary epithelium integrates
multiple and simultaneously delivered growth factor signals in
part, at the level of the duration of the MAPKERK1,2 signal. It
will be informative to develop genetic mouse models where
MAPKERK1,2 activation kinetics could be precisely controlled
within the mammary gland to test whether or not the kinetics
of MAPKERK1,2 activation is the sole determinant for the
morphogenetic outcomes observed.
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